Renaissance Technologies (RenTech)'s TMCI Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 522,900 shares of Treace Medical Concepts, Inc. (TMCI) worth $700,686, representing 0.00% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in TMCI, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 522,900 shares. Largest reduction occurred in Q4 2023, reducing 195,698 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Treace Medical Concepts (TMCI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Treace Medical Concepts (TMCI) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +522,900 | New Buy | 522,900 | $1.34 |
| Q2 2025 | -126,800 | Sold Out | 0 | $0.00 |
| Q1 2025 | +14,800 | Add 13.21% | 126,800 | $8.39 |
| Q4 2024 | +76,700 | Add 217.28% | 112,000 | $7.44 |
| Q3 2024 | -171,200 | Reduce 82.91% | 35,300 | $5.80 |
| Q2 2024 | +29,100 | Add 16.40% | 206,500 | $6.65 |
| Q1 2024 | +139,098 | Add 363.16% | 177,400 | $13.05 |
| Q4 2023 | -195,698 | Reduce 83.63% | 38,302 | $12.74 |
| Q3 2023 | +234,000 | New Buy | 234,000 | $13.11 |
| Q2 2023 | -75,600 | Sold Out | 0 | $0.00 |
| Q1 2023 | +37,900 | Add 100.53% | 75,600 | $0.03 |
| Q4 2022 | -30,900 | Reduce 45.04% | 37,700 | $0.02 |
| Q3 2022 | +68,600 | New Buy | 68,600 | $22.07 |
Renaissance Technologies (RenTech)'s Treace Medical Concepts Investment FAQs
Renaissance Technologies (RenTech) first purchased Treace Medical Concepts, Inc. (TMCI) in Q3 2022, acquiring 68,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Treace Medical Concepts, Inc. (TMCI) for 13 quarters since Q3 2022.
Renaissance Technologies (RenTech)'s largest addition to Treace Medical Concepts, Inc. (TMCI) was in Q1 2026, adding 522,900 shares worth $700,686.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 522,900 shares of Treace Medical Concepts, Inc. (TMCI), valued at approximately $700,686.
As of the Q1 2026 filing, Treace Medical Concepts, Inc. (TMCI) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Treace Medical Concepts, Inc. (TMCI) was 522,900 shares, as reported at the end of Q1 2026.